4: DHMEQ a novel therapeutic option for the treatment of inflammatory mediated cisplatin resistant non-small cell lung cancer. (January 2015) - Baird, A.-M.; Godwin, P.; Heavey, S.; Barr, M.; Umezawa, K.; Cuffe, S.; Finn, S.; O'Byrne, K.J.; Gately, K.A.